Stromacel Inc. Stock Analysis PROT
Proteonomix, Inc. is a biotechnology company, which engages in the discovery and development of stem cell therapeutic and cosmeceutical products. The company is headquartered in Mountainside, New Jersey and currently employs 1 full-time employees. The firm is a subsidiary of Proteonomix Inc. The company offers technology in the field of cellular medicine to international clients. The firm intends to conduct phased human studies of its cellular materials in application to the treatment of cardiac and other diseases.
Read More Stromacel Inc (PROT) Chart
Key Statistics of Stromacel Inc (PROT)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
250.00P/E Ratio (TTM)
-52 Week Range
Market Cap
22.80Avg. Volume
3000.00Dividend Yield
-Financial Metrics & Statements of Stromacel Inc (PROT)
FAQ's for Stromacel Inc (PROT)
- According to Musaffa’s Shariah screening methodology, Stromacel Inc (PROT) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.